DB06094InvestigationalGene Therapies
Apatorsen is a second generation antisense drug which in preclinical experiments, inhibits production of Heat Shock Protein 27 (Hsp27) a cell survival protein found at elevated levels in many human...
- Primary indication
- Investigated for use/treatment in cancer/tumors (unspecified).Curator reviewed
Resolves to
Targets
What you can answer from here — as of July 17, 2026
Which drugs share a target with Apatorsen, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account